Kei Kishimoto
Company: Selecta Biosciences Inc.
Job title: CSO
Seminars:
Strategizing Methods to Mitigate Against Neutralizing Antibodies in AAV Gene Therapy 2:00 pm
• Leveraging bacterial enzymes to circumvent neutralizing antibodies • Exploring novel approaches to dosing patients with pre-existing immunity • Optimizing neutralizing antibody assays to improve standardizationRead more
day: Day One